Treatment Outcomes and Tumor Loss of Heterozygosity in Germline DNA Repair–deficient Prostate CancerMatti Annala, Alexander W. Wyatt, Kim N. et al.|European Urology|2017Cited by 218
Evolution of Castration-Resistant Prostate Cancer in ctDNA during Sequential Androgen Receptor Pathway InhibitionMatti Annala, Alexander W. Wyatt, Sinja Taavitsainen et al.|Clinical Cancer Research|2021Cited by 94
<i>BRCA2</i> , <i>ATM</i> , and <i>CDK12</i> Defects Differentially Shape Prostate Tumor Driver Genomics and Clinical AggressionEvan W. Warner, Alexander W. Wyatt, Cameron Herberts et al.|Clinical Cancer Research|2021Cited by 87
Multiregion sampling of de novo metastatic prostate cancer reveals complex polyclonality and augments clinical genotypingEvan W. Warner, Alexander W. Wyatt, Kim Van der Eecken et al.|Nature Cancer|2024Cited by 44
Germline DNA repair mutations in metastatic castration-resistant prostate cancer: Therapy response and applicability of circulating tumor DNA.Werner J. Struss, Alexander W. Wyatt, Matti Annala et al.|Journal of Clinical Oncology|2017Cited by 3